2,296 Shares in Lam Research Corporation $LRCX Bought by Carolina Wealth Advisors LLC

Carolina Wealth Advisors LLC acquired a new position in Lam Research Corporation (NASDAQ:LRCX) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 2,296 shares of the semiconductor company’s stock, valued at approximately $393,000.

A number of other large investors have also recently made changes to their positions in LRCX. PMV Capital Advisers LLC bought a new stake in shares of Lam Research in the 4th quarter worth approximately $25,000. Stance Capital LLC bought a new stake in shares of Lam Research in the 3rd quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new stake in shares of Lam Research in the 2nd quarter worth approximately $27,000. Triumph Capital Management bought a new stake in shares of Lam Research in the 3rd quarter worth approximately $27,000. Finally, Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research in the 2nd quarter worth approximately $29,000. 84.61% of the stock is currently owned by institutional investors.

Lam Research Trading Up 1.0%

NASDAQ LRCX opened at $220.65 on Tuesday. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $256.68. The firm has a market capitalization of $275.54 billion, a PE ratio of 45.22, a P/E/G ratio of 2.35 and a beta of 1.78. The stock’s 50 day moving average is $226.97 and its 200 day moving average is $186.44.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The company had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same period in the previous year, the company posted $0.91 earnings per share. The firm’s revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be issued a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s payout ratio is 21.31%.

Insiders Place Their Bets

In other Lam Research news, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total value of $11,214,269.71. Following the sale, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Eric Brandt sold 35,000 shares of the business’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the sale, the director directly owned 253,705 shares in the company, valued at $57,235,848. This trade represents a 12.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 130,886 shares of company stock valued at $29,658,802. 0.31% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on LRCX shares. Morgan Stanley lifted their price objective on Lam Research from $254.00 to $260.00 and gave the stock an “equal weight” rating in a research report on Monday. Cantor Fitzgerald reiterated an “overweight” rating and issued a $320.00 price objective (up from $265.00) on shares of Lam Research in a research report on Thursday, January 29th. KeyCorp reiterated a “sector weight” rating on shares of Lam Research in a research report on Thursday, January 29th. Wells Fargo & Company lifted their price target on Lam Research from $250.00 to $290.00 and gave the company an “overweight” rating in a research report on Thursday, January 29th. Finally, Mizuho set a $265.00 price target on Lam Research in a research report on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $245.54.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.